Posttransplant Lymphoproliferative Disorder Presenting in the Head and Neck

Laryngoscope

Volumn 108, Issue 8, 1998, Pages 1195-1198

  Lattyak, Bruce V ^a   Rosenthal, Philip ^a   Mudge, Christine ^b   Roberts, John P ^b   Renze, John F ^b   Osorio, Robert W ^c   Emond, Jean C ^d   Lalwani, Anil K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MEMBRANE PROTEIN; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HEAD AND NECK DISEASE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; WALDEYER RING;

CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HEAD; HUMANS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; NECK; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031858625     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199808000-00018     Document Type: Article

References (15)

1. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995;59(4):524-9.
2. Aris RM, Maia DM, Neuringer IP, et al. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Part I. Am J Respir Crit Care Med 1996,154(6):1712-7.
3. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients: clinical experience and risk factor analysis in a single center. Transplantation 1993;56(1):88-96.
4. Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995;14(2):214-21.
5. Dean AF, Diss TC, Wotherspoon AC, Cox T, Nevard C. Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative disorder. Pediatr Res 1997;41(5):651-6.
6. Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol 1995;26(5):525-30.
7. Hague K, Catalano P, Rothschild M, Strauchen J, Fyfe B. Posttransplant lymphoproliferative disease presenting as sudden respiratory arrest in a three-year-old child. Ann Otol Rhinol Laryngol 1997;106(3):244-7.
8. Walker RC, Marshall WF, Strickler JG, et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 1995;20(5):1346-53.
9. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation: interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996;62(3):370-5.
10. Shapiro R, Scantlebury VP, Jordan ML, et al. Tacrolimus in pediatric renal transplantation. Transplantation 1996;62(12):1752-8.
11. Woodle ES, Thistlethwaite JR, Gordon JH, et al. A multicenter trial of FK506 (tacrolimus) therapy in refractory renal allograft rejection: a report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation 1996;62(5): 594-9.
12. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996;10(3):248-55.
13. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988;45(4):719-27.
14. Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Part II. Transplant Proc 1991;23(1):1473-6.
15. Gryczynska D, Powajbo K, Zakrzewska A. The influence of tonsillectomy on obstructive sleep apnea children with malocclusion. Int J Pediatr Otorhinolaryngol 1995;32(suppl):S225-8.